Welcome to our dedicated page for Alphatec Hldgs SEC filings (Ticker: ATEC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused medical device company. ATEC uses current reports on Form 8-K to furnish press releases on topics such as quarterly financial results, material corporate events, and board matters. For example, recent 8-K filings reference press releases announcing financial results for periods ended June 30 and September 30, 2025, as well as a release regarding the passing of a member of the Board of Directors.
In addition to 8-Ks, investors typically review ATEC’s annual reports on Form 10-K and quarterly reports on Form 10-Q for detailed discussions of its spine surgery business, revenue composition (including surgical and EOS revenue), non-GAAP metrics such as adjusted EBITDA and free cash flow, and risk factors. These periodic reports also describe the company’s Organic Innovation Machine™, InformatiX™ and AlphaInformatiX platforms, and its focus on procedural spine ecosystems.
Regulatory filings can also reflect strategic and capital structure developments, such as refinancings of convertible debt, transaction-related expenses, and non-GAAP adjustments for items like litigation-related expenses, stock-based compensation, and restructuring costs. Forms 3, 4, and 5, when filed, provide insight into insider equity transactions by directors, officers, and significant shareholders.
On Stock Titan, ATEC’s SEC filings are updated in near real time as they are posted to EDGAR. AI-powered summaries help explain the key points of lengthy documents, highlighting items such as revenue trends, segment performance, non-GAAP reconciliations, and notable risk disclosures. For complex filings like 10-Ks and 10-Qs, the AI tools surface essential information so users can quickly understand how Alphatec’s spine-focused strategy, financial profile, and regulatory disclosures are evolving without reading every page.